|
Ribavirin Capsules
|
|
Rebetol; Ribasphere
|
Ribavirin Capsules Clinical Trials
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
ClinicalTrials.gov Identifier: NCT00532701 - Recruiting
Chronic Hepatitis C; Genotype 2; Peginterferon; Ribavirin
- Therapy with Infergen, Ribavirin, & Avandia in a Group of Insulin Resistant, Chronic Hepatitis C, Genotype 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
ClinicalTrials.gov Identifier: NCT00207402 - Not yet recruiting
Hepatitis C
- Evaluation of the efficacy and safety of a high induction dose of Pegasys in combination with Copegus in patients with Chronic Hepatitis C who did not respond to previous treatment with PEG-Intron in combination with Rebetol/Ribavirin.
ClinicalTrials.gov Identifier: NCT00087646 - Active, not recruiting
Hepatitis
- Study of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
ClinicalTrials.gov Identifier: NCT00093093 - Active, not recruiting
Chronic Hepatitis C
- Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00016081 - Active, not recruiting
Infection
- Long-Term Therapy with Ribavirin for Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00001854 - Active, not recruiting
Chronic Hepatitis C
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- Zidovudine Levels in HIV Infected Patients Being Treated for HCV
ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
HIV Infections; Hepatitis C
- PEDS-C: Pegylated Interferon +/- Ribavirin for Children with Hepatitis C
ClinicalTrials.gov Identifier: NCT00100659 - Active, not recruiting
Chronic Hepatitis C
- Multicenter Study Evaluating 12 Versus 24 Weeks Therapy with Peginterferon and Ribavirin for HCV Genotype 2 or 3
ClinicalTrials.gov Identifier: NCT00143000 - Recruiting
Hepatitis C Virus
- IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3.
ClinicalTrials.gov Identifier: NCT00483938 - Recruiting
Hepatitis C, Chronic
- Evaluation of efficacy, safety and tolerability of Targretin capsules in patients with advanced or metastatic non-small cell lung cancer
ClinicalTrials.gov Identifier: NCT00050960 - Active, not recruiting
Non-small cell lung cancer
- Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C with and without Kidney Disease
ClinicalTrials.gov Identifier: NCT00028093 - Recruiting
Hepatitis C
- Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected with HCV Genotype 2 or 3
ClinicalTrials.gov Identifier: NCT00056862 - Recruiting
Hepatitis C
- Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00014391 - Active, not recruiting
Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
- Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
Hepatitis C, Chronic; Fibrosis
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
ClinicalTrials.gov Identifier: NCT00162734 - Active, not recruiting
Chronic Hepatitis C
- Peginterferon alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00018031 - Recruiting
Hepatitis C; HIV Infections
- A Study to Evaluate the Efficacy and Safety of Albuferon and Ribavirin in Interferon Naive Subjects with Chronic Hepatitis C Genotype 1
ClinicalTrials.gov Identifier: NCT00115908 - Completed
Hepatitis C, Chronic
- Study to Evaluate Drug-Drug Interaction Between Valopicitabine and Ribavirin
ClinicalTrials.gov Identifier: NCT00395421 - Active, not recruiting
Chronic Hepatitis C
- Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
ClinicalTrials.gov Identifier: NCT00277862 - Active, not recruiting
Hepatitis C
- Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C
ClinicalTrials.gov Identifier: NCT00203606 - Active, not recruiting
Hepatitis C
- Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy
ClinicalTrials.gov Identifier: NCT00299923 - Active, not recruiting
Hepatitis C, Chronic; Relapse
- Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
ClinicalTrials.gov Identifier: NCT00388882 - Active, not recruiting
Pulmonary Disease, Chronic Obstructive
- Ribavirin, Its Dosing Regime
ClinicalTrials.gov Identifier: NCT00484328 - Recruiting
Hepatitis C
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
ClinicalTrials.gov Identifier: NCT00117533 - Recruiting
Chronic Hepatitis B; Chronic Hepatitis D
- Study in Non-Responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
ClinicalTrials.gov Identifier: NCT00230854 - Active, not recruiting
Chronic Hepatitis C; Hepatitis, Viral, Human
- Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov Identifier: NCT00192647 - Active, not recruiting
Chronic Hepatitis C
- Three Regimens of PEG-Intron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548AM2)
ClinicalTrials.gov Identifier: NCT00302081 - Active, not recruiting
Hepatitis C, Chronic
- Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00421434 - Active, not recruiting
Chronic Hepatitis C
- Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
ClinicalTrials.gov Identifier: NCT00500578 - Recruiting
Hematological Malignancies
- Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
Hepatitis C, Chronic
- Lopinavir Capsules to Kaletra or Invirase Tablets
ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
HIV Infections
- 48 Weeks Combination Therapy for Patients with HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
ClinicalTrials.gov Identifier: NCT00114361 - Active, not recruiting
Hepatitis B
- An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
ClinicalTrials.gov Identifier: NCT00292084 - Active, not recruiting
Hepatitis C, Chronic
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive
ClinicalTrials.gov Identifier: NCT00230958 - Active, not recruiting
Chronic Hepatitis C
- Study to Evaluate Viral Kinetics in the First 12 Weeks of Patients With Hepatitis C Coinfected With HIV Treated With Induction Doses of Peginterferon Alpha-2a (40 KD) and Ribavirin With Epoetin β Support
ClinicalTrials.gov Identifier: NCT00356486 - Active, not recruiting
HIV Infections
- An Exploratory Study of NBI-34060 Capsules and Next Day Functioning
ClinicalTrials.gov Identifier: NCT00525941 - Recruiting
Insomnia
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection.
ClinicalTrials.gov Identifier: NCT00353418 - Active, not recruiting
Hepatitis C, Chronic
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00154869 - Recruiting
Patients with dual chronic hepatitis B and C
- Influence of Ribavirin and Interferon on Semen Quality, IRIS Study
ClinicalTrials.gov Identifier: NCT00455832 - Recruiting
Sperm Motility
- RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin
ClinicalTrials.gov Identifier: NCT00485342 - Recruiting
Chronic Hepatitis C
- Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in HCV-Genotype-1-Infection (PRAMA)
ClinicalTrials.gov Identifier: NCT00127777 - Active, not recruiting
Hepatitis C, Chronic
- Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin
ClinicalTrials.gov Identifier: NCT00382798 - Recruiting
Healthy Volunteers; Hepatitis C Virus
- Comparative Study of Pegasys plus Copegus in Treatment Naive Latino and Caucasian Patients with Chronic Hepatitis C, Genotype 1
ClinicalTrials.gov Identifier: NCT00107653 - Active, not recruiting
Hepatitis C
- Peginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients
ClinicalTrials.gov Identifier: NCT00085917 - Active, not recruiting
Hepatitis C; HIV Infections
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-Infected Patients
ClinicalTrials.gov Identifier: NCT00495131 - Recruiting
Chronic Hepatitis C
- Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients
ClinicalTrials.gov Identifier: NCT00526448 - Recruiting
Chronic Hepatitis C
- Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00532467 - Recruiting
Healthy
- Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
ClinicalTrials.gov Identifier: NCT00164073 - Recruiting
Hepatitis C
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
ClinicalTrials.gov Identifier: NCT00495391 - Recruiting
Chronic Hepatitis C
- Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
Onychomycosis of the Toenail
- Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM1)
ClinicalTrials.gov Identifier: NCT00237484 - Recruiting
Hepatitis C, Chronic
- Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
ClinicalTrials.gov Identifier: NCT00575627 - Recruiting
Chronic Hepatitis C
- Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00527540 - Recruiting
Hepatitis C
- Racial Differences in HCV/Host Interactions
ClinicalTrials.gov Identifier: NCT00071916 - Recruiting
Hepatitis C
- A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
ClinicalTrials.gov Identifier: NCT00359788 - Recruiting
Pulmonary Disease, Chronic Obstructive
- A Study of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Being Treated With Renin-Angiotensin System Inhibitors
ClinicalTrials.gov Identifier: NCT00421733 - Recruiting
Diabetic Nephropathies
- A Study of Debio 025 in Combination With Peginterferon Alpha-2a and Ribavirin in Chronic HCV Patients Non-Responders to Standard Treatment
ClinicalTrials.gov Identifier: NCT00537407 - Recruiting
Chronic Hepatitis C
- Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Efficacy and safety of Pegasys plus Copegus in patients with chronic Hepatitis C who are unable to tolerate or who do not respond to 12 weeks of therapy with PEG-Intron plus Rebetol/Ribavirin.
ClinicalTrials.gov Identifier: NCT00087568 - Completed
Hepatitis C
- Evaluation of efficacy, safety and tolerability of Targretin capsules in patients with advanced or metastatic non-small cell lung cancer
ClinicalTrials.gov Identifier: NCT00050973 - Active, not recruiting
Non-small cell lung cancer
- Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
ClinicalTrials.gov Identifier: NCT00423800 - Recruiting
Hepatitis C, Chronic
- HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy
ClinicalTrials.gov Identifier: NCT00215839 - Active, not recruiting
Chronic Hepatitis C Infection in HIV Infected Persons; HIV Infections
- A Study of Albuferon with Ribavirin in Interferon Treatment Experienced Subjects with Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00097435 - Completed
Hepatitis C
- A Study of Paclitaxel and Carboplatin in Combination with Bexarotene Oral Capsules in Patients with Advanced Lung Cancer
ClinicalTrials.gov Identifier: NCT00153842 - Active, not recruiting
Carcinoma, Non-Small-Cell Lung
- Valopicitabine Alone and Together with Pegylated Interferon in Patients with Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
ClinicalTrials.gov Identifier: NCT00120861 - Active, not recruiting
Chronic Hepatitis C
- Comparative Trial of Standard Versus Low-Dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00216775 - Recruiting
Hepatitis C, Chronic
- S-Adenosyl Methionine for Symptomatic Treatment of Primary Biliary Cirrhosis
ClinicalTrials.gov Identifier: NCT00125281 - Recruiting
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin
ClinicalTrials.gov Identifier: NCT00491179 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secrectory Conversion
ClinicalTrials.gov Identifier: NCT00160199 - Recruiting
Secondary Amenorrhea
- Retreatment of Chronic Hepatitis C Non-Responders With Pegylated Interferon Alpha + Ribavirin + Pioglitazone
ClinicalTrials.gov Identifier: NCT00433069 - Recruiting
Chronic Hepatitis C
- Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00549601 - Recruiting
Alzheimer's Disease
- Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-naïve Dialysis Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00491244 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Peginterferon Alfa-2a Plus Ribavirin and Epoetin β in HIV-Infected Patients Coinfected With Hepatitis C Virus Not Responding to Previous Treatment Regimens
ClinicalTrials.gov Identifier: NCT00470210 - Recruiting
Hepatitis C; HIV Infections
- Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
ClinicalTrials.gov Identifier: NCT00450086 - Recruiting
Collagenous Colitis
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00332176 - Recruiting
Chronic Hepatitis C
- A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
HIV Infection
- A Study of Ribavirin in the Treatment of Patients with AIDS and AIDS-Related Problems
ClinicalTrials.gov Identifier: NCT00001015 - Completed
HIV Infections
- Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)
ClinicalTrials.gov Identifier: NCT00150904 - Recruiting
hepatitis C, HIV
- An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
ClinicalTrials.gov Identifier: NCT00489385 - Recruiting
HIV Infections; HCV
- Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
Hepatitis C
- Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C
ClinicalTrials.gov Identifier: NCT00512278 - Recruiting
Hepatitis C
- A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients
ClinicalTrials.gov Identifier: NCT00000699 - Completed
HIV Infections
- Osteoarthritis of the Knee
ClinicalTrials.gov Identifier: NCT00120900 - Completed
Osteoarthritis
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00078403 - Active, not recruiting
HIV Infections; Hepatitis C; Liver Disease
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Safety and Efficacy of Ziprasidone in Adolescents With Schizophrenia
ClinicalTrials.gov Identifier: NCT00257192 - Recruiting
Schizophrenia
- Safety and Tolerability of Ziprasidone in Adolescents With Schizophrenia
ClinicalTrials.gov Identifier: NCT00265382 - Recruiting
Schizophrenia
- Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
ClinicalTrials.gov Identifier: NCT00000733 - Completed
HIV Infections
- SYREN Study: A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.
ClinicalTrials.gov Identifier: NCT00412334 - Recruiting
Hepatitis C, Chronic
- A Randomized, Controlled Trial of Fluvastatin Added to Pegylated Interferon and Ribavirin (PI+R) Versus PI+R Alone for Treatment of Chronic Hepatitis C Not Previously Treated
ClinicalTrials.gov Identifier: NCT00487318 - Recruiting
Chronic Hepatitis C
- Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance
ClinicalTrials.gov Identifier: NCT00370617 - Recruiting
Chronic Hepatitis C; Insulin Resistance
- Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00540345 - Recruiting
Chronic Hepatitis C; Genotype
- HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.
ClinicalTrials.gov Identifier: NCT00147784 - Recruiting
Opiate Dependence; Hepatitis
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
ClinicalTrials.gov Identifier: NCT00215865 - Completed
Chronic Hepatitis C Virus Infection
- Dental Pain (Following Third Molar Tooth Extraction) Study
ClinicalTrials.gov Identifier: NCT00114049 - Completed
Pain; Postoperative Pain
- A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
ClinicalTrials.gov Identifier: NCT00281606 - Not yet recruiting
HIV Infection
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
